These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22087656)

  • 1. Recent advances in biomarker discovery in solid organ transplant by proteomics.
    Sigdel TK; Sarwal MM
    Expert Rev Proteomics; 2011 Dec; 8(6):705-15. PubMed ID: 22087656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling the proteome in renal transplantation.
    Sigdel TK; Lee S; Sarwal MM
    Proteomics Clin Appl; 2011 Jun; 5(5-6):269-80. PubMed ID: 21520424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular profiling of graft injury post renal transplantation.
    Mas VR; Maluf DG
    Curr Opin Organ Transplant; 2017 Feb; 22(1):36-45. PubMed ID: 27941467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein and peptide biomarkers in organ transplantation.
    Sigdel TK; Gao X; Sarwal MM
    Biomark Med; 2012 Jun; 6(3):259-71. PubMed ID: 22731899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker discovery in transplantation--proteomic adventure or mission impossible?
    Kienzl-Wagner K; Pratschke J; Brandacher G
    Clin Biochem; 2013 Apr; 46(6):497-505. PubMed ID: 23089107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics: Its Promise and Pitfalls in Shaping Precision Medicine in Solid Organ Transplantation.
    Farkona S; Pastrello C; Konvalinka A
    Transplantation; 2023 Oct; 107(10):2126-2142. PubMed ID: 36808112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for 'omic' biomarkers.
    Lin D; Hollander Z; Meredith A; McManus BM
    Can J Cardiol; 2009 Jun; 25 Suppl A(Suppl A):9A-14A. PubMed ID: 19521568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proteogenomic path towards biomarker discovery.
    Sigdel TK; Sarwal MM
    Pediatr Transplant; 2008 Nov; 12(7):737-47. PubMed ID: 18764911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics in monitoring kidney transplants.
    Wishart DS
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):637-42. PubMed ID: 17053480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in Chronic Arthritis-Will We Finally Have Useful Biomarkers?
    Kessel C; McArdle A; Verweyen E; Weinhage T; Wittkowski H; Pennington SR; Foell D
    Curr Rheumatol Rep; 2018 Jul; 20(9):53. PubMed ID: 30008153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in diagnostics for transplant rejection.
    Nasr M; Sigdel T; Sarwal M
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1121-1132. PubMed ID: 27677432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of genomics and proteomics for the recognition of transplantation rejection of solid organs.
    Fiorini RN; Nicoud IB; Fiorini JH
    Recent Pat DNA Gene Seq; 2009; 3(1):1-6. PubMed ID: 19149732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry-based proteomics for advancing solid organ transplantation research.
    Huang CF; Su P; Fisher TD; Levitsky J; Kelleher NL; Forte E
    Front Transplant; 2023; 2():1286881. PubMed ID: 38993855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
    Stepczynska A; Schanstra JP; Mischak H
    Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deconvoluting the 'omics' for organ transplantation.
    Sarwal MM
    Curr Opin Organ Transplant; 2009 Oct; 14(5):544-51. PubMed ID: 19644370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of proteomics in biomarker discovery: a primer for the clinician.
    Tambor V; Fučíková A; Lenco J; Kacerovský M; Řeháček V; Stulík J; Pudil R
    Physiol Res; 2010; 59(4):471-497. PubMed ID: 19929137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward an integrated pipeline for protein biomarker development.
    Drabovich AP; Martínez-Morillo E; Diamandis EP
    Biochim Biophys Acta; 2015 Jun; 1854(6):677-86. PubMed ID: 25218201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards proteome standards: the use of absolute quantitation in high-throughput biomarker discovery.
    Chao TC; Hansmeier N; Halden RU
    J Proteomics; 2010 Jun; 73(8):1641-6. PubMed ID: 20399287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating protein biomarker discovery and translation from proteomics research for clinical utility.
    Chen J; Zheng N
    Bioanalysis; 2020 Oct; 12(20):1469-1481. PubMed ID: 33006485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.